How Sponsors Can Reduce Chaos at Study Sites During Decentralized Trials
Fill form to unlock content
Error - something went wrong!
Fill out this form to access your content
Decentralized clinical trials (DCTs) are here to stay. According to our 2022 state of the industry survey, 89% of research sponsors currently use and expect to continue the use of decentralized technologies and methods in at least some of their studies.
This rapid technological development will make clinical trials more accessible to participants and allow trials to reach new patient populations, ultimately accelerating research.
In this eBook we cover:
- What technology trends are guiding the the clinical trial industry
- What site risks exist when running decentralized trials
- How Sponsors can support sites with technology
- How to activate remote site collaboration through an eISF platform